Annette North Turning Point Therapeutics, Inc. (TPTX) insider trading activity

Annette North is EVP & General Counsel of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 11,696 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Feb 09, 2022, when has been sold 669 shares (Common Stock) at a price of $36.3 per share, resulting in proceeds of $24,285. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.7K

0% 3M change

0% 12M change

Total Value Held $0

Annette North Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 09 2022	SELL Open market or private sale	$24,285 $36.3 p/Share	669 Reduced 5.41%	11,696 Common Stock
Feb 09 2022	BUY Grant, award, or other acquisition	-	16,283 Added 36.79%	27,979 Common Stock
Aug 30 2021	SELL Open market or private sale	$800,000 $80.0 p/Share	10,000 Reduced 44.71%	12,365 Common Stock
Aug 30 2021	BUY Exercise of conversion of derivative security	$170,000 $17.0 p/Share	10,000 Added 30.9%	22,365 Common Stock
Jun 15 2021	SELL Open market or private sale	$1,155,600 $77.04 p/Share	15,000 Reduced 54.81%	12,365 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$255,000 $17.0 p/Share	15,000 Added 35.41%	27,365 Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	$99,994 $17.0 p/Share	5,882 Added 32.24%	12,365 Common Stock

Mar 08 2021	SELL Open market or private sale	$2,179,000 $108.95 p/Share	20,000 Reduced 75.52%	6,483 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$340,000 $17.0 p/Share	20,000 Added 43.03%	26,483 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	-	6,483 Added 50.0%	6,483 Common Stock
Feb 02 2021	SELL Open market or private sale	$1,165,318 $129.25 p/Share	9,016 Reduced 100.0%	0 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$153,272 $17.0 p/Share	9,016 Added 50.0%	9,016 Common Stock
Feb 01 2021	SELL Open market or private sale	$1,981,536 $123.97 p/Share	15,984 Reduced 100.0%	0 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$271,728 $17.0 p/Share	15,984 Added 50.0%	15,984 Common Stock

Annette North

EVP & General Counsel

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Value

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Turning Point Therapeutics, Inc.

Track Activities on TPTX

Account